You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Claims for Patent: 7,686,786

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,686,786

Title:	Dial-down mechanism for wind-up pen
Abstract:	The present invention relates to a dial-down mechanism for an injection device comprising a torsion spring for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising dial-up cam arranged to receive and engage with a dial-up key, wherein the dial-up cam and the dial-up key are adapted to, upon rotation of a dose setting member in a first direction, cooperate to strain the torsion spring of the injection device, and a dial-down cam arranged to receive and engage with a dial-down key, wherein the dial-down cam and the dial-down key are adapted to, upon rotation of the dose setting member in a second direction, cooperate to release the torsion spring of the injection device, the second rotation direction being opposite to the first rotation direction.
Inventor(s):	Moller; Claus Schmidt (Fredensborg, DK), Enggaard; Christian Peter (Vejby, DK), Radmer; Bo (Hillerod, DK), Markussen; Tom Hede (Bagsv.ae butted.rd, DK)
Assignee:	Novo Nordiks A/S (Bagsvaerd, DK)
Application Number:	11/665,486
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,686,786
Patent Claims:	1. A dial-down mechanism for an injection device comprising a torsion spring (18) for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising dial-up cam (15) arranged to receive and engage with a dial-up key (11), wherein the dial-up cam (15) and the dial-up key (11) are adapted to, upon rotation of a dose setting member in a first direction, cooperate to strain the torsion spring (18) of the injection device, and a dial-down cam (16) arranged to receive and engage with a dial-down key (12), wherein the dial-down cam (16) and the dial-down key (12) are adapted to, upon rotation of the dose setting member in a second direction, cooperate to release the torsion spring (18) of the injection device, the second rotation direction being opposite to the first rotation direction, wherein the dial-up and dial-down cams form part of regions of the same track, further comprising an arm wherein the dial-up and dial-down keys are both located on the same arm, said keys being adapted to engage and cooperate with dial-up and dial-down cams of the same track. 2. A dial-down mechanism according to claim 1, wherein the dial-up cam (15) forms part of a curved track. 3. A dial-down mechanism according to claim 2, wherein the curved dial-up cam (15) forms part of a circular, elliptical or parabolic track. 4. A dial-down mechanism according to claim 1 comprising a first and a second dial-up cam. 5. A dial-down mechanism according to claim 4 comprising a first and a second dial-up key, wherein the first dial-up key is adapted to engage and cooperate with the first dial-up cam, and wherein the second dial-up key is adapted to engage and cooperate with the second dial-up cam. 6. A dial-down mechanism according to claim 1, wherein the dial-down cam (16) forms part of a V-shaped track. 7. A dial-down mechanism according to claim 1 comprising a first and a second dial-down cam. 8. A dial-down mechanism according to claim 7 comprising a first and a second dial-down key, wherein the first dial-down key is adapted to engage and cooperate with the first dial-down cam, and wherein the second dial-down key is adapted to engage and cooperate with the second dial-down cam. 9. A medication delivery device comprising a dial-down mechanism according to claim 1. 10. A medication delivery device according to claim 9, wherein the medication delivery device is a handheld medication injection pen.

Details for Patent 7,686,786

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	June 07, 2000	7,686,786	2024-10-21
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	January 19, 2001	7,686,786	2024-10-21
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	April 23, 2004	7,686,786	2024-10-21
Novo Nordisk Inc.	NOVOLOG	insulin aspart	Injection	020986	October 31, 2013	7,686,786	2024-10-21
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	June 20, 2000	7,686,786	2024-10-21
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	October 01, 2004	7,686,786	2024-10-21
Novo Nordisk Inc.	NORDITROPIN	somatropin	Injection	021148	March 10, 2009	7,686,786	2024-10-21
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,686,786

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
South Africa	200703707	⤷ Subscribe
World Intellectual Property Organization (WIPO)	2006045526	⤷ Subscribe
United States of America	RE46363	⤷ Subscribe
United States of America	2008147005	⤷ Subscribe
Russian Federation	2389514	⤷ Subscribe
Russian Federation	2007114761	⤷ Subscribe
Poland	1804865	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.